Therapy Areas: Inflammatory Diseases
14 June 2024 - UCB, a Belgium-based global biopharmaceutical company, announced on Thursday results from three studies supporting the value of CIMZIA(R) (certolizumab pegol), a PEGylated fragment crys...
13 June 2024 - Triveni Bio Inc., a US-based biotech company developing a genetics-informed precision medicine approach to develop treatments for immunological and inflammatory (I&I) disorders, ann...
13 June 2024 - UCB, a Belgium-based global biopharmaceutical company, announced on Wednesday the first presentation of two-year data from the Phase 3 studies, BE MOBILE 1 and BE MOBILE 2, and the open...
19 April 2024 - GIE Medical, a US-based, clinical stage company, announced on Thursday that it has enrolled the first patient for its Paclitaxel Coated Balloon for the treatment of Chronic Benign Stri...
11 April 2024 - UCB, a Belgium-based global biopharmaceutical company, announced on Wednesday that it has introduced its Make HStory, an educational campaign that offers tools and resources for those ...
11 April 2024 - Sen-Jam Pharmaceutical, a New York-based innovative life sciences company, announced on Wednesday that it has signed a third strategic partnership with KVK-Tech, a US-based Specialty P...